Alembic Pharma Gets USFDA Approval

  Published 1 year ago

Alembic Pharmaceuticals has received final approval from the USFDA for its Amlodipine and Atorvastatin Tablets USP. This allows the company to market a generic version of the drug in the US market.

  • USFDA approved Alembic's ANDA.
  • Amlodipine & Atorvastatin tablets approved.
  • Expands Alembic's US generic portfolio.

You might like these

Umiya Mobile Rajkot Store Launch 2025

AGI Infra Launches 713‑Unit Luxury Towers

Force Motors Q1 PBT Surges 53%

Adobe AI Growth Sparks Analyst Debate

7 Coal Blocks Auctioned in 12th Round

Aarti Drugs Q1 Profit Up 16%

Borosil Q1 FY26 Financial Highlights

News that matters the most ⚡